Is IMPEDIMED LTD ORDINARY SHARES AUSTRALIA (OTCMKTS:IPDQF)’s Fuel Running High? Reports Show Less Sellers

ImpediMed Limited (OTCMKTS:IPDQF) Logo

The stock of IMPEDIMED LTD ORDINARY SHARES AUSTRALIA (OTCMKTS:IPDQF) registered a decrease of 9.5% in short interest. IPDQF’s total short interest was 273,400 shares in September as published by FINRA. Its down 9.5% from 302,100 shares, reported previously. With 600 shares average volume, it will take short sellers 456 days to cover their IPDQF’s short positions.

It closed at $0.136 lastly. It is up 0.00% since September 13, 2018 and is . It has by 0.00% the S&P500.

ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company has market cap of $76.10 million. The firm operates through Medical and Test & Measurement divisions. It currently has negative earnings. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patientÂ’s limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.